Direct-Acting Antivirals – hippokratia.gr

Efficacy and safety of Glecaprevir/Pibrentasvir in the treatment of mixed cryoglobulinemia due to chronic hepatitis C cirrhosis in a patient with chronic kidney disease

Posted on March 22, 2020July 21, 2022 by admin

CASE REPORT

Hippokratia 2019, 23(1): 30-32

Papadopoulos N, Flouda S, Sveroni E, Tatarida Palla M C, German V
1^st Department of Internal Medicine, 417 Army Share Fund Hospital of Athens, Greece

Real-life cost of managing chronic HCV infection in Greece prior to Direct-Acting Antivirals (DAAs): an undeniable truth of spending more for less

Posted on October 14, 2019July 21, 2022 by admin

RESEARCH ARTICLE

Hippokratia 2018, 22(3): 127-131

Souliotis K, Siakavellas S, Golna C, Manesis E, Papatheodoridis G, Hatzakis A
Department of Social and Educational Policy, Faculty of Social and Political Sciences, University of Peloponnese, Corinth, Greece, Health Policy Institute, Department of Gastroenterology, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece, Innowth Ltd, Larnaca, Cyprus, Division of Internal Medicine, Hippokration General Hospital, Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece